Practice
Open Access
Severe thrombotic complications secondary to antiphospholipid syndrome and undiagnosed systemic lupus erythematosus
Megan R.W. Barber, Ann E. Clarke, Corey D. Adams and Leslie Skeith
CMAJ September 19, 2022 194 (36) E1243-E1247; DOI: https://doi.org/10.1503/cmaj.220491
Megan R.W. Barber
Division of Rheumatology, Department of Medicine (Barber, Clarke), Cumming School of Medicine; Libin Cardiovascular Institute (Adams), Cumming School of Medicine; Division of Hematology and Hematologic Malignancies, Department of Medicine (Skeith), Cumming School of Medicine, University of Calgary, Calgary, Alta.
MD PhDAnn E. Clarke
Division of Rheumatology, Department of Medicine (Barber, Clarke), Cumming School of Medicine; Libin Cardiovascular Institute (Adams), Cumming School of Medicine; Division of Hematology and Hematologic Malignancies, Department of Medicine (Skeith), Cumming School of Medicine, University of Calgary, Calgary, Alta.
MD MScCorey D. Adams
Division of Rheumatology, Department of Medicine (Barber, Clarke), Cumming School of Medicine; Libin Cardiovascular Institute (Adams), Cumming School of Medicine; Division of Hematology and Hematologic Malignancies, Department of Medicine (Skeith), Cumming School of Medicine, University of Calgary, Calgary, Alta.
MD MScLeslie Skeith
Division of Rheumatology, Department of Medicine (Barber, Clarke), Cumming School of Medicine; Libin Cardiovascular Institute (Adams), Cumming School of Medicine; Division of Hematology and Hematologic Malignancies, Department of Medicine (Skeith), Cumming School of Medicine, University of Calgary, Calgary, Alta.
MD MHPE
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Severe thrombotic complications secondary to antiphospholipid syndrome and undiagnosed systemic lupus erythematosus
Megan R.W. Barber, Ann E. Clarke, Corey D. Adams, Leslie Skeith
CMAJ Sep 2022, 194 (36) E1243-E1247; DOI: 10.1503/cmaj.220491